NCT06301828 2024-03-08
Endostar Combined With SBRT and Envafolimab in the Treatment of Advanced Gastrointestinal Tumors
Nanjing First Hospital, Nanjing Medical University
Phase 2 Unknown
Clinical Trials
9 trialsNCT02350517 2023-02-16
Endostar Combined With Paclitaxel and Nedaplatin in Treating Patients With Recurrent or Metastatic Esophageal Cancer
Sun Yat-sen University
Phase 2 Completed
NCT05551247 2022-09-22
Envafolimab Combined With Endostatin in Recurrent or Metastatic MSS-type Colorectal Cancer
First Affiliated Hospital Xi'an Jiaotong University
Phase 2 Unknown
NCT05298020 2022-03-28
Envafolimab Combined With Endostar and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer
The Affiliated Hospital of Xuzhou Medical University
Phase 2 Unknown
NCT03208335 2017-07-05
Recombinant Human Endostatin(Rh-endostatin) Combine With Radiotherapy in the Treatment of Hepatocellular Carcinoma(HCC)
Chinese PLA General Hospital
Phase 2 Unknown
NCT02745561 2016-04-20
Endostatin in Combination With Oxaliplatin and Radiotherapy in Esophageal Cancer Patients.
Hangzhou Cancer Hospital
Phase 2 Unknown
NCT01529164 2013-11-27
Efficacy and Safety Study of Recombinant Endostatin Combined With Chemotherapy to Treat Advanced Colorectal Cancer
ChineseAMS
Phase 2 Unknown
NCT01310478 2011-03-08
Recombinant Human Endostatin in Combination With mFOLFOX6 in Patients With Metastatic Colorectal Cancer
Fudan University
Phase 1 Unknown
NCT00813137 2009-12-08
FOLFOX4 Combined With Endostar in Patients With Advanced Colorectal Cancer
Simcere Pharmaceutical Co., Ltd
Phase 2 Unknown